Categories Earnings, Health Care
Abbott Laboratories (ABT) Q2 2025 sales and earnings beat estimates
Abbott Laboratories (NYSE: ABT) on Thursday announced financial results for the second quarter of fiscal 2025, reporting an increase in sales and adjusted profit. The results also exceeded Wall Street’s estimates.
Total reported sales increased 7.4% year-over-year to $11.14 billion in the second quarter. Organic sales grew 6.9%, or 7.5% excluding COVID-19 testing-related sales.
Adjusted earnings rose to $1.26 per share in Q2 from $1.14 per share in the year-ago quarter and came in slightly above analysts’ expectations. Unadjusted profit rose sharply to $1.78 billion or $1.01 per share in the second quarter from $1.30 billion or $0.74 per share in Q2 2024.
“Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly expanded our margin profiles, and continued to advance key programs through our new product pipeline,” said Robert Ford, chief executive officer of Abbott.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CRM Earnings: Salesforce Q3 revenue up 8.6%; earnings beat estimates
Customer relationship management platform Salesforce, Inc. (NYSE: CRM) on Wednesday reported stronger-than-expected earnings for the third quarter of fiscal 2026. Revenues increased 8.6%. Adjusted net income increased to $3.25 per
Cloud Growth and AI Demand in focus as Oracle gears up for Q2 earnings
Technology giant Oracle Corporation (NYSE: ORCL) began the new fiscal year on a mixed note, reporting Q1 FY26 results that grew year over year but fell short of market expectations.
Key takeaways from Macy’s (M) Q3 2025 earnings report
Shares of Macy’s, Inc. (NYSE: M) gained over 1% in mid-day trade on Wednesday after falling earlier in the day despite the company delivering better-than-expected results for the third quarter
